PLUS THERAPEUTICS, INC. — Director's Dealing 2011

Dec 14, 2011

SEC Form 4/A — Form 4/A

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2011-12-08

Reporting Person: RICKEY DAVID (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-12-08	Common Stock	P	2100	$2.36	Acquired	77659	Indirect
2011-12-08	Common Stock	P	2900	$2.37	Acquired	80559	Indirect

Footnotes

F1: The amendment corrects a 100 share arithmetic error in the amount of securities beneficially owned following the reported transactions.